Anticorps Monoclonal anti-NeutraControl IL-23 p19
NeutraControl IL-23 p19 Monoclonal Antibody for Non-Neutralization, ELISA
Hôte / Isotype
Mouse / IgG2a
Réactivité testée
Humain, souris
Applications
Non-Neutralization, ELISA
Conjugaison
Non conjugué
CloneNo.
1A9B9
N° de cat : 69506-1-Ig
Synonymes
Galerie de données de validation
Informations sur le produit
69506-1-Ig cible IL-23 p19 dans les applications de Non-Neutralization, ELISA et montre une réactivité avec des échantillons Humain, souris
Réactivité | Humain, souris |
Hôte / Isotype | Mouse / IgG2a |
Clonalité | Monoclonal |
Type | Anticorps |
Immunogène | human Humankine IL-23 p19 protein HZ-1254 |
Nom complet | interleukin 23, alpha subunit p19 |
Symbole du gène | IL23A |
Identification du gène (NCBI) | 51561 |
Conjugaison | Non conjugué |
Forme | Lyophilized Powder |
Méthode de purification | Purification par protéine A |
Tampon de stockage | PBS stérile. |
Endotoxin | <0.1 EU/μg |
Reconstitution | This product was lyophilized from a 0.2 μm filtered solution in PBS. Reconstitute at 1.0 mg/mL in sterile H2O before use. |
Stability and Storage | Lyophilized antibodies are stable for 1 year from the date of receipt if stored between (-20°C) and (-80°C). Upon reconstitution we recommend that the solution can be stored at (4°C) for short term or at (-20°C) to (-80°C) for long term. Repeated freeze thaw cycles should be avoided with reconstituted products. |
Informations générales
Interleukin 23 (IL-23) is a member of the IL12 cytokine family and composed of two subunits, IL12p40 and IL23p19. It is produced by antigen presenting cells and has been shown to promote the production and survival of a distinct lineage of T-cells called TH17 cells. A functional receptor for IL-23 (the IL-23 receptor) has been identified and is composed of IL-12Rβ1 and IL-23R. IL-23 is expressed chiefly by the macrophages and DCs. The IL-23R is found on memory T cells, NKT cells, macrophages, DCs, and naive T cells upon activation by TGF-βand IL-6. The main biological effects of IL-23 identified initially are stimulation of antigen presentation by DCs, T cell differentiation to Th17 cells, and production of interferon-γ (IFN-γ). IL-23 acts also as an end-stage effector cytokine through direct action on macrophages (PMID: 16393998;15657292;12023369;12610626).
This antibody is a neutralizing control antibody for IL-23, the immunogen is the same as Neutrakine 69006-1-Ig but could not neutralize human IL-23.